Indoco Remedies arm commences commercial production of oral care products

Mumbai: Warren Remedies Private Limited, a Wholly Owned Subsidiary of Indoco Remedies Limited has commenced its commercial production on March 1, 2024 from its Greenfield manufacturing facility located at Aurangabad, Maharashtra to manufacture Oral Care Products.

Commenting on this occasion, Aditi Panandikar, Managing Director-Indoco Remedies Ltd. said, “It gives us immense pleasure to announce that Warren Remedies Private Limited, Wholly Owned Subsidiary of Indoco Remedies has commenced its commercial production of Oral Care Products to cater to the needs of its customers. The said manufacturing facility will provide us requisite capabilities and edge in meeting demand of Oral Care Products .”

Read also: Indoco Remedies Baddi facility gets GMP certification from EU Health Authority

Indoco is a fully integrated, research-oriented pharmaceutical company with presence in 55 countries. The Company’s turnover is US$ 200 million. The Company has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by most of the Regulatory Authorities including USFDA and UK-MHRA.

Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. Indoco has 9 domestic marketing divisions with a brand portfolio in various therapeutic segments including Gastro-intestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management, Gyneacology etc. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM 69, Methycal, Homide, Cal-Aid, etc. On the international front, Indoco has tie-ups with large generic companies across the globe.

Read also: Indoco Remedies Canagliflozin Tablets for type 2 diabetes adults get USFDA tentative okay